55 results on '"Kwee, Thomas C."'
Search Results
2. The Effect of Image Resampling on the Performance of Radiomics‐Based Artificial Intelligence in Multicenter Prostate MRI
3. Effects of control temperature, ablation time, and background tissue in radiofrequency ablation of osteoid osteoma: A computer modeling study
4. Assessment of hepatic artery anatomy in pediatric liver transplant recipients: MR angiography versus CT angiography
5. Value of detecting bone marrow involvement in Hodgkin lymphoma
6. Dynamic susceptibility MR perfusion in diagnosing recurrent brain metastases after radiotherapy: A systematic review and meta‐analysis
7. Whole‐body MRI for preventive health screening: A systematic review of the literature
8. Interim FDG‐PET does not predict outcome in advanced‐stage Hodgkin lymphoma patients treated with BEACOPP
9. Macrodactyly with a complex glomuvenous malformation in congenital lipomatous overgrowth with vascular malformations, epidermal naevi and skeletal anomalies (CLOVES) syndrome
10. Assessing complete remission status in incurable follicular lymphomas, to what purpose?
11. Post‐ ABVD biopsy results, and not post‐ ABVD FDG ‐ PET results, predict outcome in early‐stage Hodgkin lymphoma
12. Interim FDG-PET has no value in selecting patients who require treatment modification in both early- and advanced-stage Hodgkin lymphoma
13. Pretransplant FDG-PET in aggressive non-Hodgkin lymphoma: systematic review and meta-analysis
14. Hodgkin lymphoma: is there really a need for interim and end‐of‐treatmentFDG‐PETevaluations?
15. Whole-body MRI reveals high incidence of osteonecrosis in children treated for Hodgkin lymphoma
16. Controversies on the prognostic value of interim FDG-PET in advanced-stage Hodgkin lymphoma
17. Overestimated value of FDG‐PET based bone marrow evaluation in lymphoma
18. Does end-of-treatment FDG-PET provide any additional prognostic value to the pre-treatment NCCN-IPI score?
19. Is FDG-PET/CT a sensitive and specific method for the detection of extranodal involvement in diffuse large B-cell lymphoma?
20. Increased bone marrow FDG uptake at PET/CT is not a sufficient proof of bone marrow involvement in diffuse large B-cell lymphoma
21. Whole‐body MRI‐DWI for assessment of residual disease after completion of therapy in lymphoma: A prospective multicenter study
22. False-negative FDG-PET in histologically proven extensive large cell bone marrow involvement in diffuse large B-cell lymphoma
23. Prognostic value of interim FDG-PET in Hodgkin lymphoma: systematic review and meta-analysis
24. Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis
25. Prognostic superiority of the National Comprehensive Cancer Network International Prognostic Index over pretreatment whole-body volumetric-metabolic FDG-PET/CT metrics in diffuse large B-cell lymphoma
26. Paget's disease of the bone mimicking lymphomatous bone marrow involvement at FDG-PET
27. Diffusely increased bone marrow FDG uptake in recently untreated lymphoma: incidence and relevance
28. Effect of blind bone marrow biopsy on FDG-PET/CT interpretation of the posterior iliac crest in diffuse large B-cell lymphoma
29. Critical considerations on the utility of18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography for posttreatment restaging of the bone marrow in diffuse large B-cell lymphoma
30. Bone marrow18F-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography cannot replace bone marrow biopsy in diffuse large B-cell lymphoma
31. Potential prognostic implications of whole-body bone marrow MRI in diffuse large B-cell lymphoma patients with a negative blind bone marrow biopsy
32. Whole‐body MRI, including diffusion‐weighted imaging, for staging lymphoma: Comparison with CT in a prospective multicenter study
33. Low b‐value diffusion‐weighted imaging: Emerging applications in the body
34. T2‐weighted and diffusion‐weighted MRI for discriminating benign from malignant focal liver lesions: Diagnostic abilities of single versus combined interpretations
35. Gadoxetic acid disodium‐enhanced hepatocyte phase MRI: Can increasing the flip angle improve focal liver lesion detection?
36. Low b-value diffusion-weighted imaging for diagnosing strangulated small bowel obstruction: A feasibility study
37. Diffusion coefficient measurement using a temperature‐controlled fluid for quality control in multicenter studies
38. Anatomic dependency of phase shifts in the cerebral venous system of neonates at susceptibility-weighted MRI
39. Fundamentals of PET and PET/CT imaging
40. Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: Comparison with dynamic triple-phase multidetector CT imaging
41. MRI for staging lymphoma: Whole-body or less?
42. Assessment of multiexponential diffusion features as MRI cancer therapy response metrics
43. Comparison of apparent diffusion coefficients and distributed diffusion coefficients in high-grade gliomas
44. Whole-body magnetic resonance imaging, including diffusion-weighted imaging, for diagnosing bone marrow involvement in malignant lymphoma
45. Whole-body MRI for staging Hodgkin lymphoma in a pregnant patient
46. Dynamic susceptibility contrast MRI in advanced pancreatic cancer: semi-automated analysis to predict response to chemotherapy
47. Diffusion-weighted MR imaging of the liver at 3.0 Tesla using TRacking Only Navigator echo (TRON): A feasibility study
48. Intravoxel water diffusion heterogeneity imaging of human high‐grade gliomas
49. Comparison and reproducibility of ADC measurements in breathhold, respiratory triggered, and free‐breathing diffusion‐weighted MR imaging of the liver
50. Magnetic resonance imaging for the detection of bone marrow involvement in malignant lymphoma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.